Recruiting for a rare disease study is like searching for a needle in a haystack, blindfolded. Eligible patients are few, scattered, and often heavily reliant on their trusted healthcare providers.
Patient recruitment is never simple, especially when eligibility criteria are strict and timelines are tight. The right participants can be hard to find; even harder is ensuring they’re truly qualified
Timely communication isn’t just a nice-to-have in clinical trials; it’s a non-negotiable. When a potential participant expresses interest, how fast a site responds can shape the entire recruitment outcome. That
Recruiting patients for clinical trials is never simple. But when it comes to rare diseases, orphan drugs, or small patient population studies, that complexity increases tenfold. Limited patient pools, widespread
Clinical trials play a crucial role in advancing medical research and bringing new treatments to market. However, patient recruitment remains one of the most significant challenges in the clinical trial
Patient enrollment in clinical trials is essential to medical advancement, yet it remains one of the most significant challenges researchers face. Studies have shown that over 80% of clinical trials